烟肼酰胺
臨床資料 | |
---|---|
AHFS/Drugs.com | 国际药品名称 |
给药途径 | Oral |
ATC碼 | |
法律規範狀態 | |
法律規範 | |
识别信息 | |
| |
CAS号 | 51-12-7 |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.073 |
化学信息 | |
化学式 | C16H18N4O2 |
摩尔质量 | 298.35 g·mol−1 |
3D模型(JSmol) | |
| |
|
烟肼酰胺(英語:Nialamide,商品名有Niamid、Niamide、Nuredal、Surgex等)是一种含氮有机化合物,化学式C16H18N4O2,是一种可逆的,非选择性的聯氨类单胺氧化酶抑制剂,能用于抗抑郁药[2],由輝瑞公司开发,后因肝毒性问题撤回[3][4]。
参考文献
- ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. (原始内容存档于2023-08-03) (巴西葡萄牙语).
- ^ William Andrew Publishing. Pharmaceutical Manufacturing Encyclopedia 3rd. Elsevier. 1 December 2006: 2935–. ISBN 978-0-8155-1856-3.
- ^ Gad SC. Safety Pharmacology in Pharmaceutical Development: Approval and Post Marketing Surveillance, Second Edition. CRC Press. 26 April 2012: 138–. ISBN 978-1-4398-4567-7.
- ^ Shorter, Edward. Before Prozac: The Troubled History of Mood Disorders in Psychiatry: The Troubled History of Mood Disorders in Psychiatry. Oxford University Press. 28 September 2008: 137–. ISBN 978-0-19-970933-5.